For research use only. Not for use in humans.
Molecular Weight(MW): 468.94
TAE226 (NVP-TAE226) is a potent FAK inhibitor with IC50 of 5.5 nM and modestly potent to Pyk2, ~10- to 100-fold less potent against InsR, IGF-1R, ALK, and c-Met.
Selleck's TAE226 (NVP-TAE226) has been cited by 11 publications
3 Customer Reviews
Targeting the actin cytoskeleton overcomes resistance to HDACi in primary MM. Graphs representing the proportion of cell death induced in MM patients (n=6) treated LBH589 (5 nM), TAE226 (0.5 uM) and combination.
Cell Death Dis 2014 5, e1134. TAE226 (NVP-TAE226) purchased from Selleck.
Role of Tyr397-FAK phosphorylation on HCT-116 cell adhesion and migration. A) Real time adhesion assay and B) Real time migration assay in the presence of P(Tyr397)-FAK inhibitor. HCT-116 cells were treated with the P(Tyr397)-FAK inhibitor NPV-TAE226 at 0.1, 1 and 10 μM for 24 h at 37 °C, 5% CO2, and then seeded on a xCELLigence Roche 16-well plate after it had been functionalized with fibronectin. Cell adhesion and cell migration were monitored for 4 h and 24 h respectively. Each condition was analysed in quadruplicate and the experiment repeated two times.
J Inorg Biochem, 2016, 160:225-35. TAE226 (NVP-TAE226) purchased from Selleck.
The numbers of BrdU-positive cells were significantly increased by pre-treatment of NGF in SVZ and SGZ. Compared with the IgG group (a1 and a2), the numbers of BrdU-positive cells were significantly higher in the NGF group (b1 and b2). Compared with the NGF group, the numbers of BrdU-positive cells were significantly lower than in the TAE226 groups (c1 and c2) (n=3/group; *P < 0.01; **P < 0.05; 200×).
Neurosci Lett, 2018, 672:96-102. TAE226 (NVP-TAE226) purchased from Selleck.
Purity & Quality Control
Choose Selective FAK Inhibitors
|Description||TAE226 (NVP-TAE226) is a potent FAK inhibitor with IC50 of 5.5 nM and modestly potent to Pyk2, ~10- to 100-fold less potent against InsR, IGF-1R, ALK, and c-Met.|
NVP-TAE226 (< 1 μM) inhibits extracellular matrix-induced autophosphorylation of FAK (Tyr397) in serum-starved U87 cells. NVP-TAE226 (< 1 μM) also inhibits IGF-I-induced phosphorylation of IGF-1R and activity of its downstream target genes such as MAPK and Akt in both U87 and U251 cells. NVP-TAE226 (<10 μM) retards tumor cell growth and attenuats G(2)-M cell cycle progression associated with a decrease in cyclin B1 and phosphorylated cdc2 (Tyr15) protein expression in both U87 and U251 cells. NVP-TAE226 (1 μM) inhibits tumor cell invasion by at least 50% compared with the control in an in vitro Matrigel invasion assay in glioma cell lines. NVP-TAE226 (1 μM) treatment of glioma cell lines containing wild-type p53 mainly exhibits G(2)-M arrest, whereas glioma cell lines bearing mutant p53 undergoes apoptosis, as evidence by detection of caspase-3/7 activation and poly(ADP-ribose) polymerase cleavage and by an Annexin V apoptosis assay.  NVP-TAE226 (5 μM) inhibits phosphorylation of FAK in the human neuroblastoma cell line SK-N-AS. NVP-TAE226 (<10 μM) treatment of the human neuroblastoma cell line SK-N-AS leads to decrease in cellular viability, cell cycle arrest, and an increase in apoptosis.  NVP-TAE226 (0.1 μM-10 μM) inhibits tube formation of HMEC1 cells. 
|In vivo||NVP-TAE226 (75 mg/kg) significantly increases the survival rate of mice bearing intracranial glioma xenografts.  NVP-TAE226 (100 mg/kg, oral) exerts significant decrease in microvessel density in a human colon cancer model in SCID mice.  NVP-TAE226 (100 mg/kg, oral) efficiently inhibits MIA PaCa-2 human pancreatic tumor growth without body weight loss in vivo model.  NVP-TAE226 inhibits 4T1 murine breast tumor growth and metastasis to the lung in a dose-dependent manner in vivo model, associated with inhibition of FAK autophosphorylation at Y397 and Akt phosphorylation at Serine473. |
-  Liu TJ, et al. Mol Cancer Ther, 2007, 6(4), 1357-1367.
-  Beierle EA, et al. Cancer Invest, 2008, 26(2), 145-151.
-  Schultze A, et al. Invest New Drugs, 2010, 28(6), 825-833.
|In vitro||DMSO||94 mg/mL (200.45 mM)|
|In vivo||Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
For best results, use promptly after mixing.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.